(2010) Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin A proof-of-concept study
Extreme caution is warranted with any non-U.S
The risk-benefit discussion should include GI intolerance, dehydration/renal risk, gallbladder disease, pancreatitis warning symptoms, diabetic retinopathy monitoring in some patients, hypoglycemia risk when combined with insulin/sulfonylureas, and the thyroid C-cell tumor contraindication context
Individuals with a personal or familial history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should avoid semaglutide
Improved Blood Sugar Control: These peptides help regulate blood glucose levels, making them beneficial for individuals with type 2 diabetes or insulin resistance
Tell all your healthcare providers that you are taking RYBELSUS before you are scheduled to have surgery or other procedures The most common side effects of RYBELSUS may include nausea, stomach (abdominal) pain, diarrhea, decreased appetite, vomiting, and constipation
